Εσθονία -
Εσθονικά -
Ravimiamet
flavamed vaarikas suukaudne lahus
berlin-chemie ag - ambroksool - suukaudne lahus - 3mg 1ml 60ml 1tk; 3mg 1ml 100ml 1tk
Εσθονία -
Εσθονικά -
Ravimiamet
l-thyroxin berlin-chemie tablett
berlin-chemie ag - naatriumlevotüroksiin - tablett - 100mcg 100tk; 100mcg 25tk
Εσθονία -
Εσθονικά -
Ravimiamet
tramadol hcl kõvakapsel
a. menarini manufacturing logistics and services s.r.l. - tramadool - kõvakapsel - 50mg 2tk
Εσθονία -
Εσθονικά -
Ravimiamet
tramadol hcl + dexketoprofen õhukese polümeerikattega tablett
a. menarini manufacturing logistics and services s.r.l. - tramadool+deksketoprofeen - õhukese polümeerikattega tablett - 75mg+25mg 1tk
Εσθονία -
Εσθονικά -
Ravimiamet
l-thyroxin berlin-chemie tablett
ideal trade links uab - naatriumlevotüroksiin - tablett - 100mcg 50tk; 100mcg 100tk; 100mcg 25tk
Εσθονία -
Εσθονικά -
Ravimiamet
l-thyroxin berlin-chemie tablett
ideal trade links uab - naatriumlevotüroksiin - tablett - 50mcg 25tk; 50mcg 50tk; 50mcg 100tk
Ευρωπαϊκή Ένωση -
Εσθονικά -
EMA (European Medicines Agency)
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - antineoplastilised ained - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
Ευρωπαϊκή Ένωση -
Εσθονικά -
EMA (European Medicines Agency)
orserdu
stemline therapeutics b.v. - elacestrant - rinnanäärmed - endokriinset ravi - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
Ευρωπαϊκή Ένωση -
Εσθονικά -
EMA (European Medicines Agency)
anoro ellipta (previously anoro)
glaxosmithkline (ireland) limited - umeclidinium bromiid, vilanterol trifenatate - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - anoro ellipta on näidustatud hooldus bronchodilator ravi, et leevendada sümptomeid täiskasvanud patsientidel, kellel on krooniline obstruktiivne kopsuhaigus (copd).
Ευρωπαϊκή Ένωση -
Εσθονικά -
EMA (European Medicines Agency)
bretaris genuair
covis pharma europe b.v. - aclidinium bromide - kopsuhaigus, krooniline obstruktiivne - ravimid hingamisteede obstruktiivsete haiguste, - bretaris genuair on näidustatud kroonilise obstruktiivse kopsuhaiguse (kok) täiskasvanud patsientide sümptomite leevendamiseks bronhodilataatorite hoolduseks.